Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas De Leiris

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|November 12, 2020
Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CTNicolas De Leiris, Valentin Ruggeri, Laurent Riou, et al.
Clinical Nuclear Medicine|October 10, 2018
18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate CancerNicolas De Leiris, Laurent Riou, Julien Leenhardt, et al.
Clinical Nuclear Medicine|December 27, 2019
FDG PET/CT of a Supraclavicular Silicone Granuloma at Follow-up of a Breast CarcinomaOlivier Phan Sy, René-Charles Rouchy, Nicolas De Leiris, et al.
International Journal of Molecular Sciences|July 2, 2021
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?Christopher Montemagno, Shamir Cassim, Nicolas De Leiris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2025
PSMA/FDG discordance: 24-hour [177Lu]-PSMA-617 SPECT versus 60-minute [68Ga]-PSMA-11 PETAlexis Mercier, Nicolas De Leiris, Jeremie Calais, et al.
EJNMMI Radiopharmacy and Chemistry|October 26, 2023
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practicesJulien Leenhardt, Luc Choisnard, Maelle Plasse, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Development and Validation of Analytical Methods for Radiochemical Purity of <sup>177</sup>Lu-PSMA-1Pauline Orhon, Marie-Dominique Desruet, Marie Piquemal, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 TreatmentAnthime Flaus, Vincent Habouzit, Nicolas de Leiris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2021
Decrease in the cortex/striatum metabolic ratio on [<sup>18</sup>F]-FDG PET: a biomarker of autoimmune encephalitisNicolas De Leiris, Berangère Ruel, Jean Vervandier, et al.
Frontiers in Medicine|December 5, 2022
PET image enhancement using artificial intelligence for better characterization of epilepsy lesionsAnthime Flaus, Tahya Deddah, Anthonin Reilhac, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|November 12, 2020
Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CTNicolas De Leiris, Valentin Ruggeri, Laurent Riou, et al.
Clinical Nuclear Medicine|October 10, 2018
18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate CancerNicolas De Leiris, Laurent Riou, Julien Leenhardt, et al.
Clinical Nuclear Medicine|December 27, 2019
FDG PET/CT of a Supraclavicular Silicone Granuloma at Follow-up of a Breast CarcinomaOlivier Phan Sy, René-Charles Rouchy, Nicolas De Leiris, et al.
International Journal of Molecular Sciences|July 2, 2021
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?Christopher Montemagno, Shamir Cassim, Nicolas De Leiris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2025
PSMA/FDG discordance: 24-hour [177Lu]-PSMA-617 SPECT versus 60-minute [68Ga]-PSMA-11 PETAlexis Mercier, Nicolas De Leiris, Jeremie Calais, et al.
EJNMMI Radiopharmacy and Chemistry|October 26, 2023
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practicesJulien Leenhardt, Luc Choisnard, Maelle Plasse, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Development and Validation of Analytical Methods for Radiochemical Purity of <sup>177</sup>Lu-PSMA-1Pauline Orhon, Marie-Dominique Desruet, Marie Piquemal, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 TreatmentAnthime Flaus, Vincent Habouzit, Nicolas de Leiris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 31, 2021
Decrease in the cortex/striatum metabolic ratio on [<sup>18</sup>F]-FDG PET: a biomarker of autoimmune encephalitisNicolas De Leiris, Berangère Ruel, Jean Vervandier, et al.
Frontiers in Medicine|December 5, 2022
PET image enhancement using artificial intelligence for better characterization of epilepsy lesionsAnthime Flaus, Tahya Deddah, Anthonin Reilhac, et al.
Pageof 3